# Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

> **NCT03008161** · PHASE1 · COMPLETED · sponsor: **Proclara Biosciences, Inc.** · enrollment: 83 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** NPT088
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03008161
- **Lead sponsor:** Proclara Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2019-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03008161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03008161, "Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03008161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*